Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer

Схожие документы

• Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
  по: Wang, Shuai, et al.
  Опубликовано: (2018)
• Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC
  по: Shouge Zang, et al.
  Опубликовано: (2025-07-01)
• Present and Future of Efficacy Biomarkers in Immune Checkpoint Inhibitors 
of Small Cell Lung Cancer
  по: Yaning YANG, et al.
  Опубликовано: (2020-10-01)
• Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors
  по: TAKAYAMA, YUSUKE, et al.
  Опубликовано: (2021)
• Immune checkpoint inhibitors in small cell lung cancer
  по: Pakkala, Suchita, et al.
  Опубликовано: (2018)